173 related articles for article (PubMed ID: 11448225)
21. Prediction of biological activity spectra for substances: evaluation on the diverse sets of drug-like structures.
Stepanchikova AV; Lagunin AA; Filimonov DA; Poroikov VV
Curr Med Chem; 2003 Feb; 10(3):225-33. PubMed ID: 12570709
[TBL] [Abstract][Full Text] [Related]
22. Prediction of biological activity spectra via the Internet.
Sadym A; Lagunin A; Filimonov D; Poroikov V
SAR QSAR Environ Res; 2003; 14(5-6):339-47. PubMed ID: 14758978
[TBL] [Abstract][Full Text] [Related]
23. Potential drugs and nondrugs: prediction and identification of important structural features.
Wagener M; van Geerestein VJ
J Chem Inf Comput Sci; 2000 Mar; 40(2):280-92. PubMed ID: 10761129
[TBL] [Abstract][Full Text] [Related]
24. Simple selection criteria for drug-like chemical matter.
Muegge I; Heald SL; Brittelli D
J Med Chem; 2001 Jun; 44(12):1841-6. PubMed ID: 11384230
[TBL] [Abstract][Full Text] [Related]
25. PASS Targets: Ligand-based multi-target computational system based on a public data and naïve Bayes approach.
Pogodin PV; Lagunin AA; Filimonov DA; Poroikov VV
SAR QSAR Environ Res; 2015; 26(10):783-93. PubMed ID: 26305108
[TBL] [Abstract][Full Text] [Related]
26. Impact of descriptor vector scaling on the classification of drugs and nondrugs with artificial neural networks.
Givehchi A; Schneider G
J Mol Model; 2004 Jun; 10(3):204-11. PubMed ID: 15067522
[TBL] [Abstract][Full Text] [Related]
27. Predicting biotransformation potential from molecular structure.
Borodina Y; Sadym A; Filimonov D; Blinova V; Dmitriev A; Poroikov V
J Chem Inf Comput Sci; 2003; 43(5):1636-46. PubMed ID: 14502498
[TBL] [Abstract][Full Text] [Related]
28. Predicting combinative drug pairs via multiple classifier system with positive samples only.
Shi JY; Li JX; Mao KT; Cao JB; Lei P; Lu HM; Yiu SM
Comput Methods Programs Biomed; 2019 Jan; 168():1-10. PubMed ID: 30527128
[TBL] [Abstract][Full Text] [Related]
29. [Computer prediction of biological activity spectra for low-molecular peptides and peptidomimetics].
Martynova NB; Filimonov DA; Poroĭkov VV
Bioorg Khim; 2000 May; 26(5):330-9. PubMed ID: 10900503
[TBL] [Abstract][Full Text] [Related]
30. A simple method to improve the odds in finding 'lead-like' compounds from chemical libraries.
Horio K; Muta H; Goto J; Hirayama N
Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):980-4. PubMed ID: 17603185
[TBL] [Abstract][Full Text] [Related]
31. QSAR-based solubility model for drug-like compounds.
Gozalbes R; Pineda-Lucena A
Bioorg Med Chem; 2010 Oct; 18(19):7078-84. PubMed ID: 20810286
[TBL] [Abstract][Full Text] [Related]
32. Machine learning for virtual screening (part 1).
Ivanciuc O
Comb Chem High Throughput Screen; 2009 May; 12(4):330-1. PubMed ID: 19442062
[No Abstract] [Full Text] [Related]
33. In silico screening of drug databases for TSE inhibitors.
Lorenzen S; Dunkel M; Preissner R
Biosystems; 2005 May; 80(2):117-22. PubMed ID: 15823410
[TBL] [Abstract][Full Text] [Related]
34. Structural Analysis and Identification of Colloidal Aggregators in Drug Discovery.
Yang ZY; Yang ZJ; Dong J; Wang LL; Zhang LX; Ding JJ; Ding XQ; Lu AP; Hou TJ; Cao DS
J Chem Inf Model; 2019 Sep; 59(9):3714-3726. PubMed ID: 31430151
[TBL] [Abstract][Full Text] [Related]
35. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
[TBL] [Abstract][Full Text] [Related]
36. PASS: identification of probable targets and mechanisms of toxicity.
Poroikov V; Filimonov D; Lagunin A; Gloriozova T; Zakharov A
SAR QSAR Environ Res; 2007; 18(1-2):101-10. PubMed ID: 17365962
[TBL] [Abstract][Full Text] [Related]
37. Bioisosteric similarity of molecules based on structural alignment and observed chemical replacements in drugs.
Krier M; Hutter MC
J Chem Inf Model; 2009 May; 49(5):1280-97. PubMed ID: 19402687
[TBL] [Abstract][Full Text] [Related]
38. Virtual screening with support vector machines and structure kernels.
Mahé P; Vert JP
Comb Chem High Throughput Screen; 2009 May; 12(4):409-23. PubMed ID: 19442068
[TBL] [Abstract][Full Text] [Related]
39. Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds.
Tetko IV; Poda GI
J Med Chem; 2004 Nov; 47(23):5601-4. PubMed ID: 15509156
[TBL] [Abstract][Full Text] [Related]
40. Gradual in silico filtering for druglike substances.
Schneider N; Jäckels C; Andres C; Hutter MC
J Chem Inf Model; 2008 Mar; 48(3):613-28. PubMed ID: 18269264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
